GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » InnovaQor Inc (OTCPK:INQR) » Definitions » YoY EBITDA Growth

InnovaQor (InnovaQor) YoY EBITDA Growth : 0.00% (As of Sep. 2023)


View and export this data going back to . Start your Free Trial

What is InnovaQor YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. InnovaQor's YoY EBITDA Growth for the quarter that ended in Sep. 2023 was 0.00%.

InnovaQor's EBITDA per Share for the three months ended in Sep. 2023 was $-0.00.

InnovaQor YoY EBITDA Growth Historical Data

The historical data trend for InnovaQor's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnovaQor YoY EBITDA Growth Chart

InnovaQor Annual Data
Trend Jun02 Jun03 Jun04 Jun05 Jun06 Jun07 Dec21 Dec22
YoY EBITDA Growth
Get a 7-Day Free Trial - -288.10 11.04 97.24 -50.00

InnovaQor Quarterly Data
Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -200.00 -

InnovaQor YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

InnovaQor's YoY EBITDA Growth for the fiscal year that ended in Dec. 2022 is calculated as:

YoY EBITDA Growth (A: Dec. 2022 )
=(EBITDA per Share (A: Dec. 2022 )-EBITDA per Share (A: Dec. 2021 ))/ | EBITDA per Share (A: Dec. 2021 ) |
=(-0.006--0.004)/ | -0.004 |
=-50.00 %

InnovaQor's YoY EBITDA Growth for the quarter that ended in Sep. 2023 is calculated as:

YoY EBITDA Growth (Q: Sep. 2023 )
=(EBITDA per Share (Q: Sep. 2023 )-EBITDA per Share (Q: Sep. 2022 )) / | EBITDA per Share (Q: Sep. 2022 )) |
=(-0.001--0.001)/ | -0.001 |
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InnovaQor YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of InnovaQor's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

InnovaQor (InnovaQor) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » InnovaQor Inc (OTCPK:INQR) » Definitions » YoY EBITDA Growth
Comparable Companies
CBDS MITI BBLNF ACON FOXO WORX LGMK GEHC VEEV TSE:2413 ASX:PME TXG HQY DOCS RCM EVH TDOC PGNY CERT GDRX
Traded in Other Exchanges
N/A
Address
400 S. Australian Avenue, Suite 800, West Palm Beach, FL, USA, 33401
Website
https://www.innovaqor.com
InnovaQor Inc provides information technology solutions and services to healthcare and laboratory customers in the United States. Its goal is to develop and deliver a technology-based medical professional's network communication platform to a broad range of healthcare professionals and businesses using a subscription revenue model with added value bolt-on services.
Executives
Francisco Iii Roca director 400 SOUTH AUSTRALIAN AVENUE, 8TH FLOOR, WEST PALM BEACH FL 33401
Darrell L Peterson director, officer: Chief Executive Officer 2390 CIRCLE DRIVE, WEST PALM BEACH FL 33406
Sharon Lynne Hollis director 400 SOUTH AUSTRALIAN AVENUE, 8TH FLOOR, WEST PALM BEACH FL 33401
Justin Doherty director 400 S. AUSTRALIAN AVENUE, SUITE 800, WEST PALM BEACH FL 33401
Thomas Joseph Bellante officer: Chief Financial Officer 14706 CROYDON PLACE, TAMPA FL 33618
Jayne Kirby officer: VP Finance 1035 LAURIER O., SUITE 200, MONTREAL A8 H2V 2L1
Arthur Gelston 10 percent owner 1035 LAURIER STREET WEST, MONTREAL A8 H2V 2L1
Visual Healthcare Corp 10 percent owner 790 ROCKLAND AVE., MONTREAL, QC. A8 H2V 2Z6
Philippe Rainville officer: CFO 391A LAURIER WEST, MONTREAL A8 H2V 2K3
Philippe Panzini director 391A LAURIER WEST, MONTREAL A8 H2V 2K3
Michel Maksud officer: VP Technology 391A LAURIER WEST, MONTREAL A8 H2V 2K3
Gerard Dab director, officer: CEO and Chairman of the Board 391A LAURIER WEST, MONTREAL A8 H2V 2K3
Louis J Lombardo director 108 SMITH LAKE ROAD, ROSCOE NY 12776
Visualmed Clinical Systems Corp 10 percent owner
Barry Scharf officer: VP Operations 391A LAURIER WEST, MONTREAL A8 H2V 2K3